Finally, the host immune status may also be associated with survival, and Trunc‐LMP2A‐RNP could elicit more robust anti‐tumor immune responses, which may be associated with improved general health and survival rates in mice.[73, 74]. The gene discussed is RNPC3; the disease is neoplasm.